MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The Department of Health and Human Services today announced a new behavioral health initiative to assist homeless individuals with substance use…
Headline
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
The Centers for Disease Control and Prevention released its annual progress report on health care-associated infections Jan. 29, which found continued…
Headline
Zelia Baugh, senior vice president of behavioral health for JPS Health Network, and Melanie Cooper, peer support specialist for JPS Health Network, discuss how…
Blog
Despite medical advancements, maternal mortality rates have doubled since 1987. Yet more than 80% of pregnancy-related deaths have been deemed preventable.We…
Headline
The Senate Jan. 30 is expected to pass a government funding plan ahead of a midnight deadline. A partial shutdown is still set to occur as the Senate changed…